MaxCyte, Inc.

MXCT:LN

Overview

Company Profile

We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines.

Classification

Sector Healthcare

Industry Biotechnology & Life Sciences

Subindustry Life Sciences Equipment & Services

Market Sectors

Hillcrest Energy signs first commercial licensing agreement

Chart Rundown: November 9th

Mining Matters: Gold, Trump and Datacentres

Quantum Helium begins major stimulation programme at Sagebrush-1

RNS Hotlist November 9: Blackbird, Delta Gold, First Class, Galantas, Halo Minerals, Ondine, Oxford Biodynamics, Zenith Energy

Kepler | Trust Intelligence - Fidelity European

Kepler | Trust Intelligence - Baillie Gifford China Growth

Turner Pope Investments - Q3 2026 Financial Results and Trading Update

Edison - International Airlines Group:Portfolio strength underpins resilience

Edison - HgT:NAV TR of 2.0% in Q326 amid strong trading

Equity Development - ECO Animal Health - China weakness but profitability maintained

Ed Loye talks Trenching at Dough God

Zeus says Rift Helium could be worth multiples of current share price

Mining Matters - Cavendish says Blencowe Resources shares could go 500% higher

Oriole has 1.2 million ounces of gold from surface at Mbe

This commodity cycle will be bigger than 2002-2007

MaxCyte, Inc.

Overview

Company Profile

Classification

Corporate